Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing

Psychopharmacology

Volumn 227, Issue 1, 2013, Pages 41-54

  Watkins, Tristan J ^a   Raj, Vidya ^a   Lee, Junghee ^b   Dietrich, Mary S ^a,c   Cao, Aize ^c   Blackford, Jennifer U ^a,c   Salomon, Ronald M ^a   Park, Sohee ^c   Benningfield, Margaret M ^a   Di Iorio, Christina R ^a   Cowan, Ronald L ^a,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

Drug abuse; fMRI; Learning and memory; Neuroimaging; Recognition; Serotonin; Toxicity; Working memory

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ADULT; ARTICLE; BEHAVIORAL SCIENCE; BOLD SIGNAL; BRAIN CORTEX; BRAIN FUNCTION; BRAIN REGION; BRODMANN AREA 39; BRODMANN AREA 40; BRODMANN AREA 7; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; LANGUAGE PROCESSING; MALE; MULTIPLE DRUG ABUSE; NERVE STIMULATION; NEUROTOXICITY; PARIETAL CORTEX; POSTCENTRAL GYRUS; PRECUNEUS; PRIORITY JOURNAL; RESPONSE TIME; SEMANTIC MEMORY; SIGNAL DETECTION; SPEECH DISCRIMINATION; STIMULUS RESPONSE; TASK PERFORMANCE; VERBAL MEMORY;

ADOLESCENT; ADULT; BRAIN; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PROSPECTIVE STUDIES; PSYCHOMOTOR PERFORMANCE; SEMANTICS; STREET DRUGS; YOUNG ADULT;

EID: 84876014975     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-012-2936-1     Document Type: Article

References (71)

1. Back-Madruga C, Boone KB, Chang L, Grob CS, Lee A, Nations H, Poland RE (2003) Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users. Clin Neuropsychol 17:446-459
2. Bauernfeind AL, Dietrich MS, Blackford JU, Charboneau EJ, Lillevig JG, Cannistraci CJ, Woodward ND, Cao A, Watkins T, Di Iorio CR, Cascio C, Salomon RM, Cowan RL (2011) Human ecstasy use is associated with increased cortical excitability: an fMRI study. Neuropsychopharmacology 36:1127-1141
3. Bedi G, Redman J (2008) Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds. Psychol Med 38:1319-1330
4. Benningfield M, Cowan R (2012) Brain serotonin function in MDMA (ecstasy) users: evidence for persisting neurotoxicity. Neuropsychopharmacology 38:253-255
5. Binder JR, Frost JA, Hammeke TA, Cox RW, Rao SM, Prieto T (1997) Human brain language areas identified by functional magnetic resonance imaging. J Neurosci 17:353-362
6. Bondi MW, Houston WS, Eyler LT, Brown GG (2005) fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology 64:501-508
7. Brett M, Anton JL, Valabregue R, Poline JB (2002) Region of interest analysis using an SPM toolbox
8. Burgess AP, Venables L, Jones H, Edwards R, Parrott AC (2011) Event related potential (ERP) evidence for selective impairment of verbal recollection in abstinent recreational methylenedioxymethamphetamine (Ecstasy)/polydrug users. Psychopharmacology (Berl) 216:545-556
9. Canessa N, Borgo F, Cappa SF, Perani D, Falini A, Buccino G, Tettamanti M, Shallice T (2008) The different neural correlates of action and functional knowledge in semantic memory: an FMRI study. Cereb Cortex 18:740-751
10. Chan AHD, Liu HL, Yip V, Fox PT, Gao JH, Tan LH (2004) Neural systems for word meaning modulated by semantic ambiguity. NeuroImage 22:1128-1133
11. Chee MWL, O'Craven KM, Bergida R, Rosen BR, Savoy RL (1999) Auditory and visual word processing studied with fMRI. Hum Brain Mapp 7:15-28
12. Cousin E, Peyrin C, Pichat C, Lamalle L, Le Bas JF, Baciu M (2007) Functional MRI approach for assessing hemispheric predominance of regions activated by a phonological and a semantic task. Eur J Radiol 63:274-285
13. Cowan RL, Haga E, deB FB, Dietrich MS, Vimal RL, Lukas SE, Renshaw PF (2006) MDMA use is associated with increased spatial BOLD fMRI visual cortex activation in human MDMA users. Pharmacol Biochem Behav 84:219-228
14. Cowan RL, Bolo NR, Dietrich M, Haga E, Lukas SE, Renshaw PF (2007) Occipital cortical proton MRS at 4 Tesla in human moderate MDMA polydrug users. Psychiatry Res 155:179-188
15. Cowan RL, Roberts DM, Joers JM (2008a) Neuroimaging in human MDMA (Ecstasy) users. Ann N Y Acad Sci 1139:291-298
16. Cowan RL, Wood J, Dietrich MS, de BF, Lukas SE, Renshaw PF (2008b) Differential effects of d-amphetamine on red and blue light-induced photic activation: a novel BOLD fMRI assay of human dopamine function. Synapse 62:268-272
17. Cowan RL, Joers JM, Dietrich MS (2009) N-Acetylaspartate (NAA) correlates inversely with cannabis use in a frontal language processing region of neocortex in MDMA (Ecstasy) polydrug users: a 3 T magnetic resonance spectroscopy study. Pharmacol Biochem Behav 92:105-110
18. Curran HV, Verheyden SL (2003) Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function. Psychopharmacology (Berl) 169:91-103
19. de Sola LS, Miguelez-Pan M, Pena-Casanova J, Poudevida S, Farre M, Pacifici R, Bohm P, Abanades S, Verdejo GA, Langohr K, Zuccaro P, de la Torre R (2008) Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study. J Psychopharmacol 22:498-510
20. de Win MM, Reneman L, Reitsma JB, den Heeten GJ, Booij J, van den Brink W (2004) Mood disorders and serotonin transporter density in ecstasy users - the influence of long-term abstention, dose, and gender. Psychopharmacology (Berl) 173:376-382
21. D'Esposito M, Zarahn E, Aguirre GK, Rypma B (1999) The effect of normal aging on the coupling of neural activity to the bold hemodynamic response. NeuroImage 10:6-14
22. Di Iorio CR, Watkins TJ, Dietrich MS, Cao A, Blackford JU, Rogers B, Ansari MS, Baldwin RM, Li R, Kessler RM, Salomon RM, Benningfield M, Cowan RL (2012) Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users. Arch Gen Psychiatry 69:399-409
23. Easton N, Marsden CA (2006) Ecstasy: are animal data consistent between species and can they translate to humans? J Psychopharmacol 20:194-210
24. Elman I, Krause S, Breiter HC, Gollub RL, Heintges J, Baumgartner WA, Rosen BR, Gastfriend DR (2000) The validity of self-reported drug use in non-treatment seeking individuals with cocaine dependence: correlation with biochemical assays. Am J Addict 9:216-221
25. Fals-Stewart W, O'Farrell TJ, Freitas TT, McFarlin SK, Rutigliano P (2000) The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J Consult Clin Psychol 68:134-144
26. First, Michael B., Williams, Janet B.W., Spitzer, Robert L., and Gibbon, Miriam (2007) Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Clinical Trials Version (SCID-CT). New York: Biometrics Research, New York State Psychiatric Institute
27. Gibb JW, Johnson M, Stone D, Hanson GR (1990) MDMA: historical perspectives. Ann N Y Acad Sci 600:601-611
28. Giorgi FS, Pizzanelli C, Ferrucci M, Lazzeri G, Faetti M, Giusiani M, Pontarelli F, Busceti CL, Murri L, Fornai F (2005) Previous exposure to (+/-)3,4-methylenedioxymethamphetamine produces long-lasting alteration in limbic brain excitability measured by electroencephalogram spectrum analysis, brain metabolism and seizure susceptibility. Neuroscience 136:43-53
29. Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI (2003) The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy). Pharmacol Rev 55:463-508
30. Gross SR, Barrett SP, Shestowsky JS, Pihl RO (2002) Ecstasy and drug consumption patterns: a Canadian rave population study. Can J Psychiatry 47:546-551
31. Halpern JH, Sherwood AR, Hudson JI, Gruber S, Kozin D, Pope HG Jr (2011) Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs. Addiction 106:777-786
32. Hatzidimitriou G, McCann UD, Ricaurte GA (1999) Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-)3,4-methylenedioxymethamphetamine seven years previously: factors influencing abnormal recovery. J Neurosci 19:5096-5107
33. Higgs MH, Slee SJ, Spain WJ (2006) Diversity of gain modulation by noise in neocortical neurons: regulation by the slow afterhyperpolarization conductance. J Neurosci 26:8787-8799
34. Huettel SA, Singerman JD, McCarthy G (2001) The effects of aging upon the hemodynamic response measured by functional MRI. NeuroImage 13:161-175
35. Jacobsen LK, Mencl WE, Pugh KR, Skudlarski P, Krystal JH (2004) Preliminary evidence of hippocampal dysfunction in adolescent MDMA (ecstasy) users: possible relationship to neurotoxic effects. Psychopharmacology (Berl) 173:383-390
36. Kalechstein AD, De La GR, Mahoney JJ III, Fantegrossi WE, Newton TF (2007) MDMA use and neurocognition: a meta-analytic review. Psychopharmacology (Berl) 189:531-537
37. Karageorgiou J, Dietrich MS, Charboneau EJ, Woodward ND, Blackford JU, Salomon RM, Cowan RL (2009) Prior MDMA (Ecstasy) use is associated with increased basal ganglia-thalamocortical circuit activation during motor task performance in humans: an fMRI study. NeuroImage 46:817-826
38. Kim KK, Karunanayaka P, Privitera MD, Holland SK, Szaflarski JP (2011) Semantic: association investigated with functional MRI and independent component analysis. Epilepsy Behav 20:613-622
39. Kish SJ, Lerch J, Furukawa Y, Tong J, McCluskey T, Wilkins D, Houle S, Meyer J, Mundo E, Wilson AA, Rusjan PM, Saint-Cyr JA, Guttman M, Collins DL, Shapiro C, Warsh JJ, Boileau I (2010) Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study. Brain 133:1779-1797
40. Kozasa EH, Sato JR, Lacerda SS, Barreiros MA, Radvany J, Russell TA, Sanches LG, Mello LE, Amaro E Jr (2012) Meditation training increases brain efficiency in an attention task. NeuroImage 59:745-749
41. Laws KR, Kokkalis J (2007) Ecstasy (MDMA) and memory function: a meta-analytic update. Hum Psychopharmacol 22:381-388
42. Lee ACH, Robbins TW, Graham KS, Owen AM (2002) Pray or prey? Dissociation of semantic memory retrieval from episodic memory processes using positron emission tomography and a novel homophone task. NeuroImage 16:724-735
43. McCann UD, Szabo Z, Scheffel U, Dannals RF, Ricaurte GA (1998) Positron emission tomographic evidence of toxic effect of MDMA (Ecstasy) on brain serotonin neurons in human beings. Lancet 352:1433-1437
44. McCann UD, Eligulashvili V, Ricaurte GA (2000) (+/-)3,4- Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies. Neuropsychobiology 42:11-16
45. McCann UD, Szabo Z, Seckin E, Rosenblatt P, Mathews WB, Ravert HT, Dannals RF, Ricaurte GA (2005) Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB. Neuropsychopharmacology 30:1741-1750
46. McCann UD, Szabo Z, Vranesic M, Palermo M, Mathews WB, Ravert HT, Dannals RF, Ricaurte GA (2008) Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/-)3,4-methylenedioxymethamphetamine (ecstasy) users: relationship to cognitive performance. Psychopharmacology (Berl) 200:439-450
47. Medina KL, Shear PK (2007) Anxiety, depression, and behavioral symptoms of executive dysfunction in ecstasy users: contributions of polydrug use. Drug Alcohol Depend 87:303-311
48. Morgan MJ (2000) Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacology (Berl) 152:230-248
49. Motes MA, Biswal BB, Rypma B (2011) Age-dependent relationships between prefrontal cortex activation and processing efficiency. Cogn Neurosci 2:1-10
50. Oliveri M, Calvo G (2003) Increased visual cortical excitability in ecstasy users: a transcranial magnetic stimulation study. J Neurol Neurosurg Psychiatry 74:1136-1138
51. Parrott AC, Buchanan T, Scholey AB, Heffernan T, Ling J, Rodgers J (2002) Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users. Hum Psychopharmacol 17:309-312
52. Pedersen W, Skrondal A (1999) Ecstasy and new patterns of drug use: a normal population study. Addiction 94:1695-1706
53. Price CJ, Mummery CJ, Moore CJ, Frackowiak RSJ, Friston KJ (1999) Delineating necessary and sufficient neural systems with functional imaging studies of neuropsychological patients. J Cogn Neurosci 11:371-382
54. Pugh KR, Shaywitz BA, Shaywitz SE, Constable RT, Skudlarski P, Fulbright RK, Bronen RA, Shankweiler DP, Katz L, Fletcher JM, Gore JC (1996) Cerebral organization of component processes in reading. Brain 119:1221-1238
55. Quednow BB, Jessen F, Kuhn KU, Maier W, Daum I, Wagner M (2006) Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction. J Psychopharmacol 20:373-384
56. Raj V, Liang H, Woodward N, Bauernfeind A, Lee J, Dietrich M, Park S, Cowan R (2010) MDMA (ecstasy) use is associated with reduced BOLD signal change during semantic recognition in abstinent human polydrug users: a preliminary fMRI study. J Psychopharmacol 24:187-201
57. Reneman L, Booij J, de Bruin K, Reitsma JB, de Wolff FA, Gunning WB, den Heeten GJ, van den Brink W (2001) Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet 358:1864-1869
58. Reneman L, Endert E, de Bruin K, Lavalaye J, Feenstra MG, de Wolff FA, Booij J (2002) The acute and chronic effects of MDMA (ecstasy) on cortical 5-HT2A receptors in rat and human brain. Neuropsychopharmacology 26:387-396
59. Ricaurte GA, Yuan J, McCann UD (2000) (+/-)3,4- Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals. Neuropsychobiology 42:5-10
60. Sachs O, Weis S, Zellagui N, Huber W, Zvyagintsev M, Mathiak K, Kircher T (2008) Automatic processing of semantic relations in fMRI: neural activation during semantic priming of taxonomic and thematic categories. Brain Res 1218:194-205
61. Salomon RM, Cowan RL, Rogers BP, Dietrich MS, Bauernfeind AL, Kessler RM, Gore JC (2011) Time series fMRI measures detect changes in pontine raphe following acute tryptophan depletion. Psychiatry Res 191:112-121
62. Salomon RM, Karageorgiou J, Dietrich MS, McLellan JY, Charboneau EJ, Blackford JU, Cowan RL (2012) MDMA (Ecstasy) association with impaired fMRI BOLD thalamic coherence and functional connectivity. Drug Alcohol Depend 120:41-47
63. Schifano F, Di FL, Forza G, Minicuci N, Bricolo R (1998) MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients. Drug Alcohol Depend 52:85-90
64. Schilt T, de Win MM, Koeter M, Jager G, Korf DJ, van den Brink W, Schmand B (2007) Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study. Arch Gen Psychiatry 64:728-736
65. Schilt T, de Win MM, Jager G, Koeter MW, Ramsey NF, Schmand B, van den Brink W (2008) Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users. Psychol Med 38:1309-1317
66. Semple DM, Ebmeier KP, Glabus MF, O'Carroll RE, Johnstone EC (1999) Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users. Br J Psychiatry 175:63-69
67. Substance Abuse and Mental Health Services Administration, Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-41, HHS Publication No. (SMA) 11-4658. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2011
68. Thomasius R, Petersen K, Buchert R, Andresen B, Zapletalova P, Wartberg L, Nebeling B, Schmoldt A (2003) Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users. Psychopharmacology 167:85-96
69. Wagner D, Becker B, Koester P, Gouzoulis-Mayfrank E, Daumann J (2012) A prospective study of learning, memory, and executive function in new MDMA users. Addiction
70. Ward J, Hall K, Haslam C (2006) Patterns of memory dysfunction in current and 2-year abstinent MDMA users. J Clin Exp Neuropsychol 28:306-324
71. Wierenga CE, Stricker NH, McCauley A, Simmons A, Jak AJ, Chang YL, Nation DA, Bangen KJ, Salmon DP, Bondi MW (2011) Altered brain response for semantic knowledge in Alzheimer's disease. Neuropsychologia 49:392-404